Journey Medical Corp expected to post a loss of 40 cents a share - Earnings Preview

Journey Medical

09/11/2022 02:45

* Journey Medical Corp  DERM.OQ   DERM.O  is expected
to show a
fall in quarterly revenue when it reports  results on November
10. 
    * The Scottsdale Arizona-based  company is expected to
report  a
10.0% decrease in revenue to $17.653 million from $19.61 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Journey Medical
Corp is
for a loss of 40 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $9​, above​ its last closing price of $2.30. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.26       -0.26      -0.43     Missed  -67.5
 Mar. 31 2022  -0.31       -0.31      -0.08     Beat    74.2
 Dec. 31 2021  -0.45       -0.41      -1.64     Missed  -296.8
                                                        ​
 ​​                                                     
                                                        ​
 This summary was machine generated November 9 at 02:45 GMT.  All
figures in US dollars  unless otherwise stated